The discussion about key issues of lateral lymph nodes dissection for rectal cancer

doi:10.3877/cma.j.issn.2095-3224.2023.03.003

Abstract

Abstract:

Recently, due to the improvement of surgical techniques, there are more and more units in China that carry out lateral lymph nodes dissection (LLND) for rectal cancers. However, there are still some controversies over the diagnostic criteria for lateral lymph nodes metastases, indications for surgery, whether the patient benefits and other aspects. This article reviewed the historical studies of lateral lymph nodes dissection, and also reviewed key issues such as the feasibility of prophylactic lateral lymph nodes dissection, the relationship between LLND and neoadjuvant chemoradiotherapy(nCRT), and the optimal surgical indications, provided a reference for follow-up studies.

Key words: Rectal neoplasms, Lateral lymph nodes dissection, Neoadjuvant chemoradiotherapy, Total mesorectal excision

Shaotang Li. The discussion about key issues of lateral lymph nodes dissection for rectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(03): 190-195.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjzcjbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3224.2023.03.003

https://zhjzcjbdzzz.cma-cmc.com.cn/EN/Y2023/V12/I03/190

References 43

[1]	Gerota D. Die lymphgefasse des rectums und des anus [J]. Arch Anat Physiol, 1895, 7(240): 56.
[2]	Bell S, Sasaki J, Sinclair G, et al. Understanding the anatomy of lymphatic drainage and the use of blue-dye mapping to determine the extent of lymphadenectomy in rectal cancer surgery: unresolved issues [J]. Colorec Dis, 2009, 11(5): 443-449.
[3]	Miles WE. The spread of cancer of the rectum [J]. The Lancet, 1925, 205(5310): 1218-1219.
[4]	Senba Y. An anatomical study of lymphatic system of the rectum (in Japanese). [J]. J Hukuoka Med Coll, 1927, 20: 1213-1268.
[5]	Kuru M. Cancer of the rectum (in Japanese) [J]. J Jpn Surg Soc, 1940, 41: 832-877.
[6]	Coller FA, Kay EB, Macintyre RS. Regional lymphatic metastases of carcinoma of the colon [J]. Ann Surg, 1941, 114(1): 56-67.
[7]	Dukes CE. The surgical pathology of rectal cancer: president's address [J]. Proceedings of the Royal Society of Medicine, 1944, 37(4): 131-144.
[8]	Sauer I, Bacon HE. Influence of lateral spread of cancer of the rectum on radicability of operation and prognosis [J]. Am J Surg, 1951, 81(1): 111-120.
[9]	Waugh JM, Kirklin JW. The importance of the level of the lesion in the prognosis and treatment of carcinoma of the rectum and low sigmoid colon [J]. Ann Surg, 1949, 129(1): 22-33.
[10]	Stearns MW, Jr., Deddish MR. Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum [J]. Dis Colon Rectum, 1959, 2(2): 169-172.
[11]	Weiser MR. AJCC 8th edition: colorectal cancer [J]. Ann Surg Oncol, 2018, 25(6): 1454-1455.
[12]	Akiyoshi T, Watanabe T, Miyata S, et al. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? [J]. Ann Surg, 2012, 255(6): 1129-1134.
[13]	Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer [J]. N Engl J Med, 2001, 345(9): 638-646.
[14]	Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer [J]. N Engl J Med, 2004, 351(17): 1731-1740.
[15]	van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial[J]. Lancet Oncol, 2011, 12(6): 575-582.
[16]	Kusters M, Uehara K, Velde C, et al. Is there any reason to still consider lateral lymph node dissection in rectal cancer? rationale and technique [J]. Clin Colon Rectal Surg, 2017, 30(5): 346-356.
[17]	Georgiou P, Tan E, Gouvas N, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis [J]. Lancet Oncol, 2009, 10(11): 1053-1062.
[18]	Fujita S, Mizusawa J, Kanemitsu Y, et al. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial [J]. Ann Surg, 2017, 266(2): 201-207.
[19]	Fujita S, Mizusawa J, Kanemitsu Y, et al. A randomized trial comparing mesorectal excision with or without lateral lymph node dissection for clinical stage Ⅱ, Ⅲ lower rectal cancer: Primary endpoint analysis of Japan Clinical Oncology Group study JCOG0212 [J]. J Clin Oncol, 2016, 34(15_suppl): 3508-3508.
[20]	中国医师协会内镜医师分会腹腔镜外科专业委员会, 中国医师协会结直肠肿瘤专业委员会腹腔镜专业委员会, 中华医学会外科学分会结直肠外科学组. 中国直肠癌侧方淋巴结转移诊疗专家共识(2019版) [J]. 中华胃肠外科杂志, 2019, 22(10): 901-912.
[21]	MacFarlane J, Ryall R, Heald R. Mesorectal excision for rectal cancer [J]. The Lancet, 1993, 341(8843): 457-460.
[22]	Yamaguchi T, Konishi T, Kinugasa Y, et al. Laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer: a subgroup analysis of a large multicenter cohort study in Japan [J]. Dis Colon Rectum, 2017, 60(9): 954-964.
[23]	Fujita S, Akasu T, Mizusawa J, et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial [J]. Lancet Oncol, 2012, 13(6): 616-621.
[24]	Birgisson H, Påhlman L, Gunnarsson U, et al. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer [J]. J Clin Oncol, 2005, 23(25): 6126-6131.
[25]	Kusters M, Beets GL, van de Velde CJ, et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence [J]. Ann Surg, 2009, 249(2): 229-235.
[26]	Kim TH, Jeong SY, Choi DH, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection [J]. Ann Surg Oncol, 2008, 15(3): 729-737.
[27]	Kim MJ, Kim TH, Kim DY, et al. Can chemoradiation allow for omission of lateral pelvic node dissection for locally advanced rectal cancer? [J]. J Surg Oncol, 2015, 111(4): 459-464.
[28]	Malakorn S, Yang Y, Bednarski BK, et al. Who should get lateral pelvic lymph node dissection after neoadjuvant chemoradiation? [J]. Dis Colon Rectum, 2019, 62(10): 1158-1166.
[29]	Wei M, Wu Q, Fan C, et al. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial [J]. Trials, 2016, 17(1): 561.
[30]	Hoshino N, Murakami K, Hida K, et al. Diagnostic accuracy of magnetic resonance imaging and computed tomography for lateral lymph node metastasis in rectal cancer: a systematic review and meta-analysis [J]. Inter J Clin Oncol, 2019, 24(1): 46-52.
[31]	Park BK, Lee SJ, Hur BY, et al. Feasibility of selective lateral node dissection based on magnetic resonance imaging in rectal cancer after preoperative chemoradiotherapy [J]. J Surg Res, 2018, 232: 227-233.
[32]	Ogawa S, Hida J, Ike H, et al. Selection of lymph node-positive cases based on perirectal and lateral pelvic lymph nodes using magnetic resonance imaging: study of the Japanese society for cancer of the colon and rectum [J]. Ann Surg Oncol, 2016, 23(4): 1187-1194.
[33]	Lee D, Matsuda T, Yamashita K, et al. Significance of lateral pelvic lymph node size in predicting metastasis and prognosis in rectal cancer[J]. Anticancer Res, 2019, 39(2): 993-998.
[34]	Kim MJ, Hur BY, Lee ES, et al. Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings [J]. PloS One, 2018, 13(4): e0195815.
[35]	Ishihara S, Kawai K, Tanaka T, et al. Correlations between the sizes of lateral pelvic lymph nodes and metastases in rectal cancer patients treated with preoperative chemoradiotherapy [J]. ANZ Journal of Surgery, 2018, 88(12): 1306-1310.
[36]	Akiyoshi T, Matsueda K, Hiratsuka M, et al. Indications for lateral pelvic lymph node dissection based on magnetic resonance imaging before and after preoperative chemoradiotherapy in patients with advanced low-rectal cancer [J]. Ann Surg Oncol, 2015, 22(3): 614-620.
[37]	Yamaoka Y, Kinugasa Y, Shiomi A, et al. Preoperative chemoradiotherapy changes the size criterion for predicting lateral lymph node metastasis in lower rectal cancer [J]. Inter J Colorec Dis, 2017, 32(11): 1631-1637.
[38]	Ogura A, Konishi T, Beets GL, et al. Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy[J]. JAMA Surgery, 2019, 154(9): e192172.
[39]	Hojo K, Vernava AM, 3rd, Sugihara K, et al. Preservation of urine voiding and sexual function after rectal cancer surgery[J]. Dis Colon Rectum, 1991, 34(7): 532-539.
[40]	Moriya Y, Sugihara K, Akasu T, et al. Nerve-sparing surgery with lateral node dissection for advanced lower rectal cancer[J]. European Journal of Cancer (Oxford, England: 1990), 1995, 31a(7-8): 1229-1232.
[41]	Moriya Y, Sugihara K, Akasu T, et al. Patterns of recurrence after nerve-sparing surgery for rectal adenocarcinoma with special reference to loco-regional recurrence [J]. Dis Colon Rectum, 1995, 38(11): 1162-1168.
[42]	Sugihara K, Moriya Y, Akasu T, et al. Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcome [J]. Cancer, 1996, 78(9): 1871-1880.
[43]	Mori T, Takahashi K, Yasuno M. Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection [J]. Langenbecks Arch Surg, 1998, 383(6): 409-415.

Please choose a citation manager

Content to export